Telix Pharmaceuticals Limited (TLPPF)

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,328	5,098	2,224	1,563	1,606	818
Market Cap Growth	129.18%	129.18%	42.30%	-2.70%	96.45%	196.48%
Enterprise Value	6,246	5,038	2,144	1,482	1,572	801
Last Close Price	18.90	14.97	6.88	4.72	5.68	3.00
PE Ratio	204.85	165.02	626.21	-	-	-
PS Ratio	10.52	10.52	6.49	14.37	290.85	203.32
PB Ratio	14.50	14.50	21.91	28.75	1023.78	13.41
P/TBV Ratio	54.17	54.17	83.14	109.40	-	53.46
P/FCF Ratio	578.16	578.16	229.72	-	-	619.12
P/OCF Ratio	191.44	191.44	136.63	-	-	540.78
EV/Sales Ratio	12.51	10.39	6.26	13.62	284.54	199.24
EV/EBITDA Ratio	108.96	92.95	55.00	-	-	-
EV/EBIT Ratio	119.63	99.41	60.60	-	-	-
EV/FCF Ratio	708.39	571.37	221.37	-	-	606.68
Debt / Equity Ratio	1.02	1.02	0.12	0.13	1.18	0.03
Debt / EBITDA Ratio	6.47	6.47	0.30	-	-	-
Debt / FCF Ratio	40.81	40.81	1.23	-	-	1.29
Asset Turnover	0.81	0.81	1.52	0.88	0.06	0.04
Inventory Turnover	10.79	10.79	15.36	10.92	1.25	3.45
Quick Ratio	2.60	2.60	1.18	1.90	1.13	4.62
Current Ratio	2.78	2.78	1.41	2.02	1.25	4.69
Return on Equity (ROE)	13.92%	13.92%	4.55%	-253.34%	-198.36%	-60.21%
Return on Assets (ROA)	5.33%	5.33%	9.81%	-25.37%	-37.95%	-23.64%
Return on Capital (ROIC)	7.78%	7.78%	25.26%	-97.35%	-118.20%	-40.13%
Return on Capital Employed (ROCE)	6.91%	6.91%	21.54%	-	-	-
Earnings Yield	0.49%	0.61%	0.16%	-4.53%	-3.64%	-4.23%
FCF Yield	0.14%	0.17%	0.44%	-3.09%	-2.75%	0.16%
Buyback Yield / Dilution	-6.63%	-6.63%	-4.21%	-10.08%	-9.69%	-10.21%
Total Shareholder Return	-6.63%	-6.63%	-4.21%	-10.08%	-9.69%	-10.21%

Source: S&P Capital IQ. Standard template. Financial Sources.